Bereum, a pioneering force in postbiotic, has recently inked a strategic collaboration with Hyundai Corporation Group to venture into the North American market. The contract, valued at $10 million, marks a significant milestone in the company's journey, positioning it as the sole domestic competitor to Japan in the burgeoning next-generation postbiotics sector.
With an aim for global export, leveraging its esteemed technological capabilities, Bereum has partnered with NURA, a prominent U.S. distributor specializing in food ingredients. The contract entails a minimum purchase quantity (MOQ) of $10 million (approximately 130 billion KRW) over the course of three years.
In a concerted effort to bolster its presence in North America, Bereum, in conjunction with NURA, participated in the Natural Foods Expo West held in Anaheim, USA, from March 14th to 16th. This platform served as an avenue to introduce Bereum's groundbreaking postbiotic solutions to the discerning U.S. market.
Postbiotic, heralded as the next-generation probiotics, addresses the limitations of conventional probiotics by enhancing heat resistance, thereby widening its applicability across various industries spanning F&B, cosmetics, and pharmaceuticals. With its acclaimed benefits including intestinal health and immune regulation, postbiotic has emerged as a transformative force in the probiotics landscape.
According to industry experts, the postbiotic market presently stands at approximately 2.6 trillion KRW, with a commendable average annual growth rate of 7.21%. Projections indicate a surge to 4.3 trillion KRW by 2030. [Source: 360iRescarch]
Bereum, a stalwart in postbiotic with over three decades of dedicated focus, stands as a formidable entity in the global arena, fiercely competing with Japanese counterparts. Recognized by the Ministry of Economy and Finance as the sole high-tech entity in the domestic food industry, Bereum's prowess has garnered international acclaim. Allied Market Research, a renowned global market research firm, has identified Bereum as a key player in the postbiotic domain.
Backed by a robust portfolio of certifications including GRAS certification and GMP in the United States, alongside a prolific publication record featuring over 30 SCI-level papers, Bereum exemplifies unwavering commitment to technological excellence.
With an extensive clientele comprising over 200 domestic F&B enterprises and burgeoning interest from pharmaceutical giants, Bereum's footprint extends far and wide. The company's proprietary brand products, introduced since 2022, have garnered widespread acclaim both domestically and internationally.
Having forged a strategic alliance with Hyundai Corporation Group as a strategic investor (SI) in 2022, Bereum has embarked on a trajectory of global expansion. The company secured a landmark postbiotic supply contract in Europe in 2023, facilitated by Hyundai Corporation Group's expansive global network. Bereum has also made significant strides in exporting to Southeast Asia, Central and South America, including Malaysia.
The recent foray into the U.S. market, facilitated by Hyundai Corporation Group, underscores Bereum's burgeoning global footprint. This contract signifies the inaugural step in establishing Bereum's technological prowess in the pivotal U.S. probiotics market, laying the groundwork for future endeavors.
Lily Ruan, CEO of Nura, expressed enthusiasm regarding the collaboration, stating, "I am delighted to introduce Bereum's postbiotics to Nura's clientele, given Bereum's esteemed status as a frontrunner in the postbiotics domain. With Bereum's postbiotics, we aim to spearhead the microbiome trend, catering to diverse brands in health foods, beverages, and beyond."
Han Kwon-il, CEO of Bereum, articulated ambitious plans for the company's global expansion, stating, "Embarking on our journey with the North American market, we are poised to scale our export operations worldwide. As pioneers in postbiotics technology, we remain steadfast in our commitment to showcase Korea's technological prowess, spearheading innovation across postbiotics raw materials, food, cosmetics, and pharmaceuticals."